End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 22 | 3Sbio Inc. Announces Management Changes | CI |
Apr. 15 | 3SBIO Gets China Nod for Use of Cancer Injection in Children with Thrombocytopenia | MT |
Sales 2023 | 7.82B 1.08B | Sales 2024 * | 8.66B 1.2B | Capitalization | 15.01B 2.07B |
---|---|---|---|---|---|
Net income 2023 | 1.55B 214M | Net income 2024 * | 1.94B 268M | EV / Sales 2023 | 2.37 x |
Net Debt 2023 | 2.15B 297M | Net Debt 2024 * | 830M 115M | EV / Sales 2024 * | 1.83 x |
P/E ratio 2023 |
11
x | P/E ratio 2024 * |
8.27
x | Employees | - |
Yield 2023 * |
2.55% | Yield 2024 * |
3.46% | Free-Float | 73.92% |
Managers | Title | Age | Since |
---|---|---|---|
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Xiang He
DFI | Director of Finance/CFO | - | 23-07-02 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bin Huang
BRD | Director/Board Member | 63 | 92-12-31 |
Jing Lou
CEO | Chief Executive Officer | 61 | 92-12-31 |
Dong Mei Su
BRD | Director/Board Member | 54 | 12-06-10 |
1st Jan change | Capi. | |
---|---|---|
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-15.94% | 31.09B | |
+52.66% | 24.74B | |
-14.50% | 15.91B | |
-9.12% | 11.96B | |
-14.38% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |